Elemar Piros
Analyst
Lucid Capital Markets
Equibles does not estimate personal net worth.
About Elemar Piros
Elemar Piros is recorded as Analyst at Lucid Capital Markets. Elemar Piros has spoken on 1 earnings call across 1 company, most recently for NRX Pharmaceuticals, Inc. on November 17, 2026. The companies whose calls Elemar Piros spoke on are classified in the Healthcare sector.
Elemar Piros on recent calls
“The preservative-free ketamine, which you used to call kata-free, does that have a name, a new name, or you stay with kata-free?”
Affiliation history
-
Lucid Capital Markets
Analyst
Transcript header (unverified)
Current